Vivos Inc. Announces Expanded Applications of IsoPet® for Veterinary Cancer Therapy
January 11, 2019 07:00 ET
|
Vivos Inc.
Richland WA, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTCPINK: RDGL), announced that the device classification obtained from the FDA Center for Veterinary Medicine (CVM) is not limited to...
Zomedica Announces Achievement of Therapeutic Development Milestones
December 12, 2017 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Zomedica Opens Investigational New Animal Drug Application with FDA Center for Veterinary Medicine for Anti-diarrheal Medication ZM-007
December 19, 2016 06:55 ET
|
Zomedica
Complements previously announced ZM-012 formulation for dogs ANN ARBOR, Mich., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company,...
Zomedica Opens First Investigational New Animal Drug Application with FDA Center for Veterinary Medicine
May 10, 2016 07:45 ET
|
Zomedica Corp.
ANN ARBOR, Mich., May 10, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company, today announced that it opened its first Investigational New...